AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Naloxone Hydrochloride in South Africa
4 products registered with SAHPRA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| SABAX NALOXONE 0,02 mg/ml | Z/1.4/3 | Adcock Ingram Critical Care (Pty) Ltd | active | 1 Jan 1900 |
| NALOXONE HCL 0,4 mg/1 ml FRESENIUS | 27/1.4/0157 | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | 1 Jan 1900 |
| NALOXONE HCl NEONATAL 0,02 mg/1 ml FRESENIUS | 27/1.4/0158 | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | 1 Jan 1900 |
| PHARMA-Q NALOXONE INJECTION 0,4 mg/ml | 34/1.4/0165 | Pharma-Q Holdings (Pty) Ltd | active | 1 Jan 1900 |
Naloxone Hydrochloride — SAHPRA Registration Details
SAHPRA (South Africa) has 4 registered products containing Naloxone Hydrochloride, of which 4 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Naloxone Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.